LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,053
تعداد مقالات9,691
تعداد مشاهده مقاله12,896,656
تعداد دریافت فایل اصل مقاله6,145,113
Zarafshani, Mohammadkian, Mahmoodzadeh, Habibollah, Soleimani, Vahid, Moosavi, Mohammad Amin, Rahmati, Marveh. (1402). Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients. سامانه مدیریت نشریات علمی, (), -. doi: 10.30476/ijms.2023.96922.2856
Mohammadkian Zarafshani; Habibollah Mahmoodzadeh; Vahid Soleimani; Mohammad Amin Moosavi; Marveh Rahmati. "Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients". سامانه مدیریت نشریات علمی, , , 1402, -. doi: 10.30476/ijms.2023.96922.2856
Zarafshani, Mohammadkian, Mahmoodzadeh, Habibollah, Soleimani, Vahid, Moosavi, Mohammad Amin, Rahmati, Marveh. (1402). 'Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients', سامانه مدیریت نشریات علمی, (), pp. -. doi: 10.30476/ijms.2023.96922.2856
Zarafshani, Mohammadkian, Mahmoodzadeh, Habibollah, Soleimani, Vahid, Moosavi, Mohammad Amin, Rahmati, Marveh. Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients. سامانه مدیریت نشریات علمی, 1402; (): -. doi: 10.30476/ijms.2023.96922.2856

Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients

Iranian Journal of Medical Sciences
مقالات آماده انتشار، اصلاح شده برای چاپ، انتشار آنلاین از تاریخ 14 شهریور 1402    اصل مقاله (1.26 M)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2023.96922.2856
نویسندگان
Mohammadkian Zarafshani1، 2؛ Habibollah Mahmoodzadeh2؛ Vahid Soleimani3؛ Mohammad Amin Moosavi4؛ Marveh Rahmati* 1
1Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
2Division of Surgical Oncology, Department of Surgery, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
3Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
4Department of Molecular Medicine, Institute of Medical Biotechnology (IMB), National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
چکیده
Background: Three main cell signaling pathways including the endoplasmic reticulum stress (ERS) response, autophagy, and apoptosis play critical roles in both cell survival and death. They were found to crosstalk with one another during tumorigenesis and cancer progression. This study aimed to investigate the expression of the spliced form of X-box binding protein 1 (XBP1s), p62, and caspase-3, as the essential biomarkers of ERS, autophagy, and apoptosis in patients with colorectal cancer (CRC), as well as the correlation between their expression and clinicopathological data. 
Methods: This retrospective study was conducted on formalin-fixed paraffin-embedded (FFPE) blocks, which were collected from patients and their tumor margins, from the tumor bank of Imam Khomeini Hospital (Tehran, Iran) from 2017 to 2019. Tissue microarray (TMA) was used to measure the XBP1s, p62, and caspase-3 biomarkers. Data were analyzed using SPSS software version 20, and P≤0.05 was considered statistically significant. 
Results: Evaluating the total of 91 patients, a significant relationship was found between XBP1s expression and TNM stage (P=0.003), primary tumor (pT) (P=0.054), and the degree of differentiation (P=0.006); and between caspase-3 with pT (P=0.004), and lymphovascular invasion (P=0.02). However, no significant correlation was found between p62 and clinicopathological data. Furthermore, a positive relationship between XBP1s and p62 was confirmed (correlation coefficient: 22.2% and P=0.05).
Conclusion: Our findings indicated that XBP1s could be considered as a target for therapy in personalized medicine.
کلیدواژه‌ها
Apoptosis؛ Autophagy؛ Caspase-3؛ Colorectal neoplasm؛ Endoplasmic reticulum stress
مراجع
  1. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145-64. doi: 10.3322/caac.21601. PubMed PMID: 32133645.
  2. De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P, et al. Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015;34:1087-96. doi: 10.3892/or.2015.4108. PubMed PMID: 26151224; PubMed Central PMCID: PMCPMC4530899.
  3. Mokarram P, Albokashy M, Zarghooni M, Moosavi MA, Sepehri Z, Chen QM, et al. New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. Autophagy. 2017;13:781-819. doi: 10.1080/15548627.2017.1290751. PubMed PMID: 28358273; PubMed Central PMCID: PMCPMC5446063.
  4. Kim H, Bhattacharya A, Qi L. Endoplasmic reticulum quality control in cancer: Friend or foe. Semin Cancer Biol. 2015;33:25-33. doi: 10.1016/j.semcancer.2015.02.003. PubMed PMID: 25794824; PubMed Central PMCID: PMCPMC4523434.
  5. Jin C, Jin Z, Chen NZ, Lu M, Liu CB, Hu WL, et al. Activation of IRE1alpha-XBP1 pathway induces cell proliferation and invasion in colorectal carcinoma. Biochem Biophys Res Commun. 2016;470:75-81. doi: 10.1016/j.bbrc.2015.12.119. PubMed PMID: 26742428.
  6. Dai W, Li Q, Liu BY, Li YX, Li YY. Differential networking meta-analysis of gastric cancer across Asian and American racial groups. BMC Syst Biol. 2018;12:51. doi: 10.1186/s12918-018-0564-z. PubMed PMID: 29745833; PubMed Central PMCID: PMCPMC5998874.
  7. Li XX, Zhang HS, Xu YM, Zhang RJ, Chen Y, Fan L, et al. Knockdown of IRE1alpha inhibits colonic tumorigenesis through decreasing beta-catenin and IRE1alpha targeting suppresses colon cancer cells. Oncogene. 2017;36:6738-46. doi: 10.1038/onc.2017.284. PubMed PMID: 28825721.
  8. Huang J, Pan H, Wang J, Wang T, Huo X, Ma Y, et al. Unfolded protein response in colorectal cancer. Cell Biosci. 2021;11:26. doi: 10.1186/s13578-021-00538-z. PubMed PMID: 33514437; PubMed Central PMCID: PMCPMC7844992.
  9. Riaz TA, Junjappa RP, Handigund M, Ferdous J, Kim HR, Chae HJ. Role of Endoplasmic Reticulum Stress Sensor IRE1alpha in Cellular Physiology, Calcium, ROS Signaling, and Metaflammation. Cells. 2020;9. doi: 10.3390/cells9051160. PubMed PMID: 32397116; PubMed Central PMCID: PMCPMC7290600.
  10. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005;74:739-89. doi: 10.1146/annurev.biochem.73.011303.074134. PubMed PMID: 15952902.
  11. Shi W, Chen Z, Li L, Liu H, Zhang R, Cheng Q, et al. Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells. J Cancer. 2019;10:2035-46. doi: 10.7150/jca.29421. PubMed PMID: 31205564; PubMed Central PMCID: PMCPMC6548171.
  12. Santana-Codina N, Mancias JD, Kimmelman AC. The Role of Autophagy in Cancer. Annu Rev Cancer Biol. 2017;1:19-39. doi: 10.1146/annurev-cancerbio-041816-122338. PubMed PMID: 31119201; PubMed Central PMCID: PMCPMC6527373.
  13. Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy. 2021;17:1-382. doi: 10.1080/15548627.2020.1797280. PubMed PMID: 33634751; PubMed Central PMCID: PMCPMC7996087.
  14. Wang X, Xu Y, Li T, Chen B, Yang W. Development of prognosis model for colon cancer based on autophagy-related genes. World J Surg Oncol. 2020;18:285. doi: 10.1186/s12957-020-02061-w. PubMed PMID: 33126898; PubMed Central PMCID: PMCPMC7602324.
  15. Qian HR, Shi ZQ, Zhu HP, Gu LH, Wang XF, Yang Y. Interplay between apoptosis and autophagy in colorectal cancer. Oncotarget. 2017;8:62759-68. doi: 10.18632/oncotarget.18663. PubMed PMID: 28977986; PubMed Central PMCID: PMCPMC5617546.
  16. Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, et al. Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest. 2001;81:681-8. doi: 10.1038/labinvest.3780277. PubMed PMID: 11351040.
  17. Rahmati M, Amanpour S, Mohammadpour H. The role of nanoparticles in cancer therapy through apoptosis induction. Nanoparticle Drug Deliv Syst Cancer Treat. 2020:45-74. doi: 10.1201/9780429341250-3.
  18. Zhou M, Liu X, Li Z, Huang Q, Li F, Li CY. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. Int J Cancer. 2018;143:921-30. doi: 10.1002/ijc.31374. PubMed PMID: 29524226; PubMed Central PMCID: PMCPMC6204286.
  19. Nogueira RB, Pires AR, Soares TM, Rodrigues SR, Campos MA, Toloi GC, et al. Immunoexpression of the COX-2, p53, and caspase-3 proteins in colorectal adenoma and non-neoplastic mucosa. Einstein (Sao Paulo). 2013;11:456-61. doi: 10.1590/s1679-45082013000400009. PubMed PMID: 24488384; PubMed Central PMCID: PMCPMC4880382.
  20. Arani RH, Mohammadpour H, Moosavi MA, Muhammadnejad A, Abdollahi A, Rahmati M. The Role of Autophagy-related Proteins of Beclin-1/BECN1, LC3II, and p62/SQSTM1 in Melanoma Tumors. Asian Pacific Journal of Cancer Biology. 2021;6:263-72. doi: 10.31557/apjcb.2021.6.4.263-272.
  21. Feldman AT, Wolfe D. Tissue processing and hematoxylin and eosin staining. Methods Mol Biol. 2014;1180:31-43. doi: 10.1007/978-1-4939-1050-2_3. PubMed PMID: 25015141.
  22. Rai PD, Vagha S, Shukla S, Bhake A. Comparison of various scoring systems by immunohistochemistry for evaluating hormone receptors (Estrogen receptor and progesterone receptor) in carcinoma of breast. Journal of Datta Meghe Institute of Medical Sciences University. 2020;15:202-8. doi: 10.4103/jdmimsu.jdmimsu_7_20.
  23. Flanagan L, Meyer M, Fay J, Curry S, Bacon O, Duessmann H, et al. Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach. Cell Death Dis. 2016;7:e2087. doi: 10.1038/cddis.2016.7. PubMed PMID: 26844701; PubMed Central PMCID: PMCPMC4849164.
  24. Bagratuni T, Wu P, Gonzalez de Castro D, Davenport EL, Dickens NJ, Walker BA, et al. XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood. 2010;116:250-3. doi: 10.1182/blood-2010-01-263236. PubMed PMID: 20421453.
  25. Bortnik S, Gorski SM. Clinical Applications of Autophagy Proteins in Cancer: From Potential Targets to Biomarkers. Int J Mol Sci. 2017;18. doi: 10.3390/ijms18071496. PubMed PMID: 28696368; PubMed Central PMCID: PMCPMC5535986.
  26. Holdenrieder S, Stieber P. Apoptotic markers in cancer. Clin Biochem. 2004;37:605-17. doi: 10.1016/j.clinbiochem.2004.05.003. PubMed PMID: 15234242.
  27. Jiang Y, Zhou Y, Zheng Y, Guo H, Gao L, Chen P, et al. Expression of inositol-requiring enzyme 1beta is downregulated in colorectal cancer. Oncol Lett. 2017;13:1109-18. doi: 10.3892/ol.2017.5590. PubMed PMID: 28454221; PubMed Central PMCID: PMCPMC5403352.
  28. Fujimoto T, Yoshimatsu K, Watanabe K, Yokomizo H, Otani T, Matsumoto A, et al. Overexpression of human X-box binding protein 1 (XBP-1) in colorectal adenomas and adenocarcinomas. Anticancer Res. 2007;27:127-31. PubMed PMID: 17352224.
  29. Mhaidat NM, Alzoubi KH, Abushbak A. X-box binding protein 1 (XBP-1) enhances colorectal cancer cell invasion. J Chemother. 2015;27:167-73. doi: 10.1179/1973947815Y.0000000006. PubMed PMID: 25692573.
  30. Chen S, Chen J, Hua X, Sun Y, Cui R, Sha J, et al. The emerging role of XBP1 in cancer. Biomed Pharmacother. 2020;127:110069. doi: 10.1016/j.biopha.2020.110069. PubMed PMID: 32294597.
  31. Ariosa AR, Lahiri V, Lei Y, Yang Y, Yin Z, Zhang Z, et al. A perspective on the role of autophagy in cancer. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166262. doi: 10.1016/j.bbadis.2021.166262. PubMed PMID: 34481059; PubMed Central PMCID: PMCPMC8488024.
  32. Iwadate R, Inoue J, Tsuda H, Takano M, Furuya K, Hirasawa A, et al. High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer. Am J Pathol. 2015;185:2523-33. doi: 10.1016/j.ajpath.2015.05.008. PubMed PMID: 26162509.
  33. Iwadate R, Inoue J, Tsuda H, Takano M, Furuya K, Hirasawa A, et al. High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer. Acta Histochem Cytochem. 2014;47:295-301. doi: 10.1267/ahc.14048. PubMed PMID: 25859063; PubMed Central PMCID: PMCPMC4387266.
  34. Schmitz KJ, Ademi C, Bertram S, Schmid KW, Baba HA. Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status. World J Surg Oncol. 2016;14:189. doi: 10.1186/s12957-016-0946-x. PubMed PMID: 27444698; PubMed Central PMCID: PMCPMC4957418.
  35. Niklaus M, Adams O, Berezowska S, Zlobec I, Graber F, Slotta-Huspenina J, et al. Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer. Oncotarget. 2017;8:54604-15. doi: 10.18632/oncotarget.17554. PubMed PMID: 28903368; PubMed Central PMCID: PMCPMC5589607.
  36. Nakayama S, Karasawa H, Suzuki T, Yabuuchi S, Takagi K, Aizawa T, et al. p62/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferation. Cancer Med. 2017;6:1264-74. doi: 10.1002/cam4.1093. PubMed PMID: 28544335; PubMed Central PMCID: PMCPMC5463080.
  37. Lei C, Zhao B, Liu L, Zeng X, Yu Z, Wang X. Expression and clinical significance of p62 protein in colon cancer. Medicine (Baltimore). 2020;99:e18791. doi: 10.1097/MD.0000000000018791. PubMed PMID: 32011477; PubMed Central PMCID: PMCPMC7220407.
  38. Zhao Y, Li X, Cai MY, Ma K, Yang J, Zhou J, et al. XBP-1u suppresses autophagy by promoting the degradation of FoxO1 in cancer cells. Cell Res. 2013;23:491-507. doi: 10.1038/cr.2013.2. PubMed PMID: 23277279; PubMed Central PMCID: PMCPMC3616429.
آمار
تعداد مشاهده مقاله: 2,860
تعداد دریافت فایل اصل مقاله: 163


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب